Krista M. Rodgers

Krista M. Rodgers

Auto-generated profile, based on publicly available information

Krista M. Rodgers

Department of Psychology and Neuroscience, University of Colorado, Boulder, Colorado 80309, and

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2008 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
KRKrista M. Rodgers
Krista M. Rodgers
ABAlexander M. Benison
Alexander M. Benison
AKAndrea Klein
Andrea Klein
DBDaniel S. Barth
Daniel S. Barth
Compared with other areas of the forebrain, the function of insular cortex is poorly understood. This study examined the unisensory and multisensory function of the rat insula using high-resolution, whole-hemisphere, epipial evoked potential mapping. We found the posterior insula to contain distinct auditory and somatotopically organized somatosensory fields with an interposed and overlapping region capable of integrating these sensory modalities. Unisensory and multisensory responses were uninfluenced by complete lesioning of primary and secondary auditory and somatosensory cortices, suggesting a high degree of parallel afferent input from the thalamus. In light of the established connections of the posterior insula with the amygdala, we propose that integration of auditory and somatosensory modalities reported here may play a role in auditory fear conditioning.

30 June 2009 in Brain
Verified
Journal Article
Open access
PDF file
KRKrista M. Rodgers
Krista M. Rodgers
MHMark R Hutchinson
Mark R Hutchinson
ANAlexis Northcutt
Alexis Northcutt
SMSteven F. Maier
Steven F. Maier
LWLinda R. Watkins
Linda R. Watkins
DBDaniel S. Barth
Daniel S. Barth
Brain glial cells, five times more prevalent than neurons, have recently received attention for their potential involvement in epileptic seizures. Microglia and astrocytes, associated with inflammatory innate immune responses, are responsible for surveillance of brain damage that frequently results in seizures. Thus, an intriguing suggestion has been put forward that seizures may be facilitated and perhaps triggered by brain immune responses. Indeed, recent evidence strongly implicates innate immune responses in lowering seizure threshold in experimental models of epilepsy, yet, there is no proof that they can play an independent role in initiating seizures in vivo. Here, we show that cortical innate immune responses alone produce profound increases of brain excitability resulting in focal seizures. We found that cortical application of lipopolysaccharide, binding to toll-like receptor 4 (TLR4), triples evoked field potential amplitudes and produces focal epileptiform discharges. These effects are prevented by pre-application of interleukin-1 receptor antagonist. Our results demonstrate how the innate immune response may participate in acute seizures, increasing neuronal excitability through interleukin-1 release in response to TLR4 detection of the danger signals associated with infections of the central nervous system and with brain injury. These results suggest an important role of innate immunity in epileptogenesis and focus on glial inhibition, through pharmacological blockade of TLR4 and the pro-inflammatory mediators released by activated glia, in the study and treatment of seizure disorders in humans.

17 June 2015 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
KRKrista M. Rodgers
Krista M. Rodgers
FDF. Edward Dudek
F. Edward Dudek
DBDaniel S. Barth
Daniel S. Barth
Variable-duration oscillations and repetitive, high-voltage spikes have been recorded in the electrocorticogram (ECoG) of rats weeks and months after fluid percussion injury (FPI), a model of traumatic brain injury. These ECoG events, which have many similarities to spike-wave-discharges (SWDs) and absence seizures, have been proposed to represent nonconvulsive seizures characteristic of post-traumatic epilepsy (PTE). The present study quantified features of SWD episodes in rats at different time points after moderate to severe FPI, and compared them with age-matched control rats. Control and FPI-injured rats at 1 year of age displayed large-amplitude and frequent SWD events at frontal and parietal recording sites. At 3–6 months, SWDs were shorter in duration and less frequent; extremely brief SWDs (i.e., “larval”) were detected as early as 1 month. The onset of the SWDs was nearly always synchronous across electrodes and of larger amplitude in frontal regions. A sensory stimulus, such as a click, immediately and consistently stopped the occurrence of the SWDs. SWDs were consistently accompanied by behavioral arrest. All features of SWDs in control and experimental (FPI) rats were indistinguishable. None of the FPI-treated rats developed nonconvulsive or convulsive seizures that could be distinguished electrographically or behaviorally from SWDs. Because SWDs have features similar to genetic absence seizures, these results challenge the hypothesis that SWDs after FPI reflect PTE.

1 January 2017 in Cell Reports
Verified
Journal Article
Open access
GDGuiying Deng
Guiying Deng
JOJames E. Orfila
James E. Orfila
RDRobert M. Dietz
Robert M. Dietz
MMMyriam Moreno-Garcia
Myriam Moreno-Garcia
KRKrista M. Rodgers
Krista M. Rodgers
PHPaco S. Herson
Paco S. Herson
The Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a major mediator of physiological glutamate signaling, but its role in pathological glutamate signaling (excitotoxicity) remains less clear, with indications for both neuro-toxic and neuro-protective functions. Here, the role of CaMKII in ischemic injury is assessed utilizing our mouse model of cardiac arrest and cardiopulmonary resuscitation (CA/CPR). CaMKII inhibition (with tatCN21 or tatCN19o) at clinically relevant time points (30 min after resuscitation) greatly reduces neuronal injury. Importantly, CaMKII inhibition also works in combination with mild hypothermia, the current standard of care. The relevant drug target is specifically Ca2+-independent "autonomous" CaMKII activity generated by T286 autophosphorylation, as indicated by substantial reduction in injury in autonomy-incompetent T286A mutant mice. In addition to reducing cell death, tatCN19o also protects the surviving neurons from functional plasticity impairments and prevents behavioral learning deficits, even at extremely low doses (0.01 mg/kg), further highlighting the clinical potential of our findings.

1 November 2014 in Neuroscience
Verified
Journal Article
Closed access
PGPeter Grace
Peter Grace
KRK M Ramos
K M Ramos
KRK M Rodgers
K M Rodgers
XWXiaohui Wang
Xiaohui Wang
MHMark R Hutchinson
Mark R Hutchinson
LWL R Watkins
L R Watkins

15 February 2018 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
ACAmy C. Clevenger
Amy C. Clevenger
HKHoon Kim
Hoon Kim
ESErnesto Salcedo
Ernesto Salcedo
JYJoan C. Yonchek
Joan C. Yonchek
KRKrista M. Rodgers
Krista M. Rodgers
PHPaco S. Herson
Paco S. Herson